CN111671090A - Probiotic composition and preparation thereof - Google Patents
Probiotic composition and preparation thereof Download PDFInfo
- Publication number
- CN111671090A CN111671090A CN202010456985.4A CN202010456985A CN111671090A CN 111671090 A CN111671090 A CN 111671090A CN 202010456985 A CN202010456985 A CN 202010456985A CN 111671090 A CN111671090 A CN 111671090A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- fermentation culture
- vitamin
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 131
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 131
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 112
- 238000002360 preparation method Methods 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 241000894006 Bacteria Species 0.000 claims abstract description 52
- 239000003223 protective agent Substances 0.000 claims abstract description 35
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 31
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 30
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 30
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 29
- 241000193755 Bacillus cereus Species 0.000 claims abstract description 24
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 24
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 24
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 24
- 241000186684 Lactobacillus pentosus Species 0.000 claims abstract description 24
- 241000186869 Lactobacillus salivarius Species 0.000 claims abstract description 24
- 241000192041 Micrococcus Species 0.000 claims abstract description 24
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 24
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims abstract description 23
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims abstract description 23
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims description 95
- 230000004151 fermentation Effects 0.000 claims description 95
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 43
- 239000004373 Pullulan Substances 0.000 claims description 43
- 229920001218 Pullulan Polymers 0.000 claims description 43
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 43
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 43
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 43
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 43
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 43
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 43
- 235000019423 pullulan Nutrition 0.000 claims description 43
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 24
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 24
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 24
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 20
- 239000001963 growth medium Substances 0.000 claims description 18
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 15
- 229930003268 Vitamin C Natural products 0.000 claims description 15
- 229930003316 Vitamin D Natural products 0.000 claims description 15
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 15
- 235000019154 vitamin C Nutrition 0.000 claims description 15
- 239000011718 vitamin C Substances 0.000 claims description 15
- 235000019166 vitamin D Nutrition 0.000 claims description 15
- 239000011710 vitamin D Substances 0.000 claims description 15
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 15
- 229940045997 vitamin a Drugs 0.000 claims description 15
- 229940046008 vitamin d Drugs 0.000 claims description 15
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 14
- 239000011719 vitamin A Substances 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 239000011726 vitamin B6 Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 7
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- 241000588748 Klebsiella Species 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 5
- 229960002160 maltose Drugs 0.000 claims description 5
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 claims description 4
- 229960001305 cysteine hydrochloride Drugs 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- -1 vitamin a Chemical compound 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 13
- 230000004083 survival effect Effects 0.000 abstract description 13
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000029087 digestion Effects 0.000 abstract description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 25
- 230000000694 effects Effects 0.000 description 16
- 239000004310 lactic acid Substances 0.000 description 15
- 235000014655 lactic acid Nutrition 0.000 description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
- 241000186660 Lactobacillus Species 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 229930003270 Vitamin B Natural products 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000011720 vitamin B Substances 0.000 description 6
- 235000019156 vitamin B Nutrition 0.000 description 6
- 210000004534 cecum Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000194046 Streptococcus intermedius Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000006153 eosin methylene blue Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/167—Pentosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of probiotics, in particular to a probiotic composition and a preparation thereof, wherein the probiotic composition comprises the following raw materials in parts by weight: 0.5-4 parts of streptococcus thermophilus, 0.5-2 parts of lactobacillus acidophilus, 0.5-2.5 parts of lactobacillus bulgaricus, 0.5-2 parts of bifidobacterium lactis, 0.5-1.5 parts of micrococcus krusei, 1.5-2.5 parts of bacillus subtilis, 0.5-1.5 parts of lactobacillus pentosus, 0.5-1.2 parts of lactobacillus salivarius, 2-4 parts of bacillus cereus, 0.5-1 part of saccharomycete and 6-10 parts of protective agent. The probiotic composition has high viable bacteria survival rate, and can promote intestinal digestion and absorption, and effectively regulate intestinal flora ecosystem balance.
Description
Technical Field
The invention relates to the technical field of probiotics, in particular to a probiotic composition and a preparation thereof.
Background
Probiotics are bacteria that produce lactic acid when carbohydrates such as glucose are utilized. Probiotics share the common feature of growing both aerobically and anaerobically, i.e., they are mostly facultative anaerobes. The probiotics has close relationship with human, is the most important probiotic group in human intestinal tracts, and has important effects on nutrition, immunity, health care, even anti-aging and longevity of human bodies. The higher the proportion of probiotics in the human intestinal tract, the better the micro-ecological environment and the more young and active the intestinal tract.
The probiotics are roughly divided into three groups, including lactobacillus (such as lactobacillus acidophilus, lactobacillus casei, lactobacillus jensenii, lactobacillus raman and the like), bifidobacterium (such as bifidobacterium longum, bifidobacterium breve, bifidobacterium ovorans, bifidobacterium thermophilum and the like), gram-positive coccus (such as streptococcus faecalis, lactococcus lactis, streptococcus intermedius and the like), and the probiotics have the following functions in combination: (1) improving immunity: a large amount of immunoglobulin is generated to activate immune cells of an organism, so that external bacteria are difficult to remain in the body, and the immunoregulation effect is achieved; (2) improving the gastrointestinal tract function: a protective barrier is formed on the surface of the intestinal mucosa to resist the invasion and damage of harmful bacteria to the intestinal mucosa, so that an environment which is not beneficial to the growth of the harmful bacteria is created, and the growth and the propagation of the harmful bacteria are inhibited; (3) the nutrition function is as follows: lactic acid and acetic acid are produced by fermentation, so that the utilization rate of calcium, phosphorus and iron can be improved, and digestion and absorption of related nutrient substances are promoted; (4) bowel relaxing and moistening: can generate a large amount of acidic substances in the intestines to stimulate the intestinal peristalsis and play a role in relaxing the bowels. Therefore, research and development on probiotics and related preparations can bring positive promotion significance to human health.
Patent application CN105641209A discloses a probiotic composition for improving immunity, which comprises probiotic dry powder, astragalus extract powder and medlar extract powder supplemented with nutritional ingredients such as vitamin K, vitamin B12, pyridoxine, biotin, folic acid, nicotinic acid and thiamine, and has the advantages of more ingredients, high raw material cost, and probiotic bacteria in living bacteria, easy loss of activity in transportation and storage processes, high acidity and high permeability in gastrointestinal tract and environment containing various hydrolytic enzymes, and great threat to probiotic bacteria, easy inactivation, difficulty in having enough living bacteria to reach intestinal tract or definite value in intestinal tract to play a probiotic role, and thus, space for improvement is provided.
Disclosure of Invention
Aiming at the defects in the prior art, one of the purposes of the invention is to provide a probiotic composition which has high live bacteria survival rate in the transportation and storage processes, can promote the digestion and absorption of intestinal tracts and effectively regulates the ecological system balance of intestinal flora.
The above object of the present invention is achieved by the following technical solutions:
the probiotic composition comprises the following raw materials in parts by weight: 0.5-4 parts of streptococcus thermophilus, 0.5-2 parts of lactobacillus acidophilus, 0.5-2.5 parts of lactobacillus bulgaricus, 0.5-2 parts of bifidobacterium lactis, 0.5-1.5 parts of micrococcus krusei, 1.5-2.5 parts of bacillus subtilis, 0.5-1.5 parts of lactobacillus pentosus, 0.5-1.2 parts of lactobacillus salivarius, 2-4 parts of bacillus cereus, 0.5-1 part of saccharomycete and 6-10 parts of protective agent.
Further, the feed comprises the following raw materials in parts by weight: 0.5-2 parts of streptococcus thermophilus, 1-2 parts of lactobacillus acidophilus, 1-2.5 parts of lactobacillus bulgaricus, 1-2 parts of bifidobacterium lactis, 0.5-1 part of micrococcus krusei, 2-2.5 parts of bacillus subtilis, 0.5-1.5 parts of lactobacillus pentosus, 0.5-1.0 part of lactobacillus salivarius, 2-3 parts of bacillus cereus, 0.5-1 part of saccharomycete and 6-9 parts of a protective agent.
Further, the feed comprises the following raw materials in parts by weight: 1.8 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.6 parts of bifidobacterium lactis, 0.9 part of micrococcus klebsiella, 2.2 parts of bacillus subtilis, 1.0 part of lactobacillus pentosus, 0.8 part of lactobacillus salivarius, 2.5 parts of bacillus cereus, 0.6 part of yeast and 7 parts of protective agent.
Further, the probiotic composition also contains maltose, vitamin A, vitamin C, vitamin D and vitamin B6And microcrystalline cellulose.
Further, the protective agent comprises glycyrrhizic acid and pullulan.
Furthermore, the mass ratio of the glycyrrhizic acid to the pullulan is 1: (2.5-4).
According to the invention, probiotics are reasonably matched, and the ratio of the probiotics is adjusted, so that the effect of the probiotics is exerted to the maximum extent, the intestinal digestion and absorption are promoted, the proliferation of harmful bacteria is inhibited, and the intestinal flora is effectively adjusted; the inventor unexpectedly finds that the glycyrrhizic acid and the pullulan are added into the probiotic composition according to a certain proportion, so that the growth of the probiotics can be enhanced after the probiotics reach the intestinal tract, the activity of the probiotics is effectively improved, and the growth of escherichia coli is inhibited, wherein the glycyrrhizic acid and the pullulan are mixed according to a mass ratio of 1: (2.5-4) when the probiotic composition is added, the activity of the probiotics is better, the intestinal digestion and absorption are better promoted, and the intestinal flora is effectively adjusted.
The second purpose of the invention is to provide a probiotic preparation prepared from the probiotic composition and a medically acceptable carrier, the probiotic preparation has high live bacteria survival rate and can be stored for a long time, the storage time of the probiotic preparation at normal temperature is longer, and the shelf value is improved.
The invention also provides a preparation method of the probiotic preparation, which comprises the following steps:
s1, respectively inoculating lactobacillus bulgaricus, bifidobacterium lactis, micrococcus krusei, bacillus subtilis, lactobacillus pentosus, lactobacillus salivarius, bacillus cereus and saccharomycetes into a fermentation culture medium for fermentation culture, and ending the fermentation culture when the number of viable bacteria reaches a standard to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, and adding microcrystalline cellulose into the fermentation culture medium before fermentation is finished to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, and then adding glycyrrhizic acid, pullulan, maltose, vitamin A, vitamin C, vitamin D and vitamin B6Mixing to obtain compound;
and S4, sequentially granulating, rounding and vacuum drying the compound obtained in the step S3 to obtain the probiotic preparation.
Further, the viable count in the step S1 is 3.5-4.5 × 109And (5) finishing the fermentation culture when cfu/ml is reached.
Furthermore, the main components of the fermentation medium comprise 85-90 g/L of glucose, 5-14 g/L of yeast extract, 10-12 g/L of sodium citrate, 1-2.6 g/L, L-dipotassium phosphate, 0.2-0.6 g/L of cysteine hydrochloride and 2-4 g/L of magnesium sulfate.
The preparation method of the probiotic preparation is simple, safe, pollution-free and low in production cost, and maltose, vitamin A, vitamin C, vitamin D and vitamin B are added into the probiotic preparation6According to the invention, microcrystalline cellulose is added into the fermentation culture medium before the fermentation in step S2 is finished, so that the stability of the probiotic preparation is improved, the storage time of the probiotic preparation is prolonged, and the storage time of the probiotic preparation at normal temperature is prolonged.
In summary, the invention includes at least one of the following beneficial technical effects:
1. the invention provides a probiotic composition, which has high live bacteria survival rate, can promote intestinal digestion and absorption, and effectively regulates the ecological system balance of intestinal flora;
2. the invention provides a probiotic composition, wherein glycyrrhizic acid and pullulan are added into the probiotic composition according to a certain proportion, so that the growth of probiotics can be enhanced after the probiotics reach the intestinal tract, the activity of the probiotics is effectively improved, and the activity of escherichia coli is inhibited;
the invention provides a probiotic preparation, which is characterized in that microcrystalline cellulose is added before the fermentation of streptococcus thermophilus and lactobacillus acidophilus is finished, so that the fermentation time can be reduced, the storage time of the probiotic preparation can be prolonged, and the shape of the probiotic preparation is more stable.
Detailed Description
The present invention will be described in further detail below.
Example 1A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
0.5 part of streptococcus thermophilus, 0.5 part of lactobacillus acidophilus, 0.5 part of lactobacillus bulgaricus, 0.5 part of bifidobacterium lactis, 0.5 part of micrococcus kluyveri, 1.5 parts of bacillus subtilis, 0.5 part of lactobacillus pentosus, 0.5 part of lactobacillus salivarius, 2 parts of bacillus cereus, 0.5 part of yeast and 6 parts of protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 2.5.
Example 2A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
1.5 parts of streptococcus thermophilus, 1 part of lactobacillus acidophilus, 1 part of lactobacillus bulgaricus, 1 part of bifidobacterium lactis, 0.8 part of micrococcus krusei, 1.7 parts of bacillus subtilis, 1 part of lactobacillus pentosus, 1 part of lactobacillus salivarius, 3 parts of bacillus cereus, 0.7 part of yeast and 8 parts of protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1:3.
Example 3A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
2 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.5 parts of bifidobacterium lactis, 1 part of micrococcus keschnei, 2 parts of bacillus subtilis, 1.2 parts of lactobacillus pentosus, 1 part of lactobacillus salivarius, 3 parts of bacillus cereus, 0.8 part of yeast and 9 parts of protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 3.5.
Example 4A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
4 parts of streptococcus thermophilus, 2 parts of lactobacillus acidophilus, 2.5 parts of lactobacillus bulgaricus, 2 parts of bifidobacterium lactis, 1.5 parts of micrococcus krusei, 2.5 parts of bacillus subtilis, 1.5 parts of lactobacillus pentosus, 1.2 parts of lactobacillus salivarius, 4 parts of bacillus cereus, 1 part of yeast and 10 parts of protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 4.
Example 5A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
1.8 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.6 parts of bifidobacterium lactis, 0.9 part of micrococcus klebsiella, 2.2 parts of bacillus subtilis, 1.0 part of lactobacillus pentosus, 0.8 part of lactobacillus salivarius, 2.5 parts of bacillus cereus, 0.6 part of yeast and 7 parts of protective agent.
The protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 3.2.
Example 6A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
0.5 part of streptococcus thermophilus, 0.5 part of lactobacillus acidophilus, 0.5 part of lactobacillus bulgaricus, 0.5 part of bifidobacterium lactis, 0.5 part of micrococcus kluyveri, 1.5 parts of bacillus subtilis, 0.5 part of lactobacillus pentosus, 0.5 part of lactobacillus salivarius, 2 parts of bacillus cereus, 0.5 part of saccharomycete, 0.6 part of maltose, 0.1 part of vitamin A, 0.3 part of vitamin C, 0.3 part of vitamin D, and vitamin B60.2 part, 2 parts of microcrystalline cellulose and 6 parts of a protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 2.5.
Example 7A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
1.5 parts of streptococcus thermophilus, 1 part of lactobacillus acidophilus, 1 part of lactobacillus bulgaricus, 1 part of bifidobacterium lactis, 0.8 part of micrococcus krusei, 1.7 parts of bacillus subtilis, 1 part of lactobacillus pentosus, 1 part of lactobacillus salivarius, 3 parts of bacillus cereus, 0.7 part of saccharomycete, 0.5 part of maltose, 0.2 part of vitamin A, 0.2 part of vitamin C, 0.4 part of vitamin D, and vitamin B60.2 part, 1 part of microcrystalline cellulose and 8 parts of a protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1:3.
Example 8A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
2 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.5 parts of bifidobacterium lactis, 1 part of micrococcus klebsiella, 2 parts of bacillus subtilis, 1.2 parts of lactobacillus pentosus, 1 part of lactobacillus salivarius, 3 parts of bacillus cereus, 0.8 part of saccharomycete, 0.6 part of maltose, 0.1 part of vitamin A, 0.1 part of vitamin C, 0.4 part of vitamin D, and vitamin B60.4 part, 1.8 parts of microcrystalline cellulose and 9 parts of a protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 3.5.
Example 9A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
4 parts of streptococcus thermophilus, 2 parts of lactobacillus acidophilus, 2.5 parts of lactobacillus bulgaricus, 2 parts of bifidobacterium lactis, 1.5 parts of micrococcus krusei, 2.5 parts of bacillus subtilis, 1.5 parts of lactobacillus pentosus, 1.2 parts of lactobacillus salivarius, 4 parts of bacillus cereus, 1 part of saccharomycete, 0.5 part of maltose, 0.3 part of vitamin A, 0.3 part of vitamin C, 0.2 part of vitamin D, and vitamin B60.2 part, 2 parts of microcrystalline cellulose and 10 parts of a protective agent;
the protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 4.
Example 10A probiotic composition
The probiotic composition comprises the following raw materials in parts by weight:
1.8 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.6 parts of bifidobacterium lactis, 0.9 part of micrococcus klebsiella, 2.2 parts of bacillus subtilis, 1.0 part of lactobacillus pentosus, 0.8 part of lactobacillus salivarius, 2.5 parts of bacillus cereus, 0.6 part of saccharomycete, 0.6 part of maltose, 0.3 part of vitamin A, 0.3 part of vitamin C, 0.2 part of vitamin D, and vitamin B60.2 part, 1.4 parts of microcrystalline cellulose and 7 parts of a protective agent.
The protective agent comprises glycyrrhizic acid and pullulan, and the mass ratio of the glycyrrhizic acid to the pullulan is 1: 3.2.
Example 11A probiotic preparation and method of preparation
A preparation method of a probiotic preparation comprises the following steps:
s1, respectively inoculating the lactobacillus bulgaricus, the bifidobacterium lactis, the micrococcus krusei, the bacillus subtilis, the lactobacillus pentosus, the lactobacillus salivarius, the bacillus cereus and the yeast in the weight parts of the example 6 into a fermentation culture medium for fermentation culture, wherein the culture temperature is 35 ℃, and the viable count reaches 3.5 × 109When cfu/ml is reached, ending the fermentation culture to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, wherein the temperature of a fermentation culture sample is 35 ℃, and when the number of viable bacteria reaches 4.2 × 109When cfu/ml is needed, adding microcrystalline cellulose in the weight part of the example 6 into a fermentation medium, and fermenting for 1h to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, mixing for 30min, and then adding the glycyrrhizic acid, the pullulan, the maltose, the vitamin A, the vitamin C, the vitamin D and the vitamin B in the weight parts of the embodiment 66Mixing to obtain compound;
s4, sequentially passing the compound obtained in the step S3 through a granulator, a spheronizer and a dryer to obtain a probiotic preparation;
the main components of the fermentation medium comprise 85g/L glucose, 5g/L yeast extract, 10g/L sodium citrate, 1g/L, L-dipotassium phosphate-0.2 g/L cysteine hydrochloride and 2g/L magnesium sulfate.
Example 12A probiotic formulation and method of preparation
A preparation method of a probiotic preparation comprises the following steps:
s1, respectively inoculating the lactobacillus bulgaricus, the bifidobacterium lactis, the micrococcus krusei, the bacillus subtilis, the lactobacillus pentosus, the lactobacillus salivarius, the bacillus cereus and the yeast in the weight parts of the example 7 into a fermentation culture medium for fermentation culture, wherein the culture temperature is 30 ℃, and the viable count reaches 3.8 × 109When cfu/ml is reached, ending the fermentation culture to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, wherein the temperature of a fermentation culture sample is 35 ℃, and when the number of viable bacteria reaches 4.0 × 109When cfu/ml is needed, adding microcrystalline cellulose in the weight part of the example 7 into a fermentation medium, and fermenting for 1.5h to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, mixing for 35min, and then adding the glycyrrhizic acid, the pullulan, the maltose, the vitamin A, the vitamin C, the vitamin D and the vitamin B in the weight parts of the embodiment 76Mixing to obtain compound;
s4, sequentially granulating, rounding, drying at low temperature in vacuum and coating the compound obtained in the step S3 by using a granulator, a rounding machine, a dryer and a coating machine to obtain the probiotic preparation;
the main components of the fermentation medium comprise 87g/L glucose, 10g/L yeast extract, 11g/L sodium citrate, 1.5g/L, L-dipotassium phosphate-0.4 g/L cysteine hydrochloride and 3g/L magnesium sulfate.
Example 13A probiotic preparation and method of preparation
A preparation method of a probiotic preparation comprises the following steps:
s1, respectively taking the weight portions of the product obtained in the example 8Inoculating Lactobacillus gasseri, Bifidobacterium lactis, Micrococcus clarkii, Bacillus subtilis, Lactobacillus pentosus, Lactobacillus salivarius, Bacillus cereus and yeast into fermentation medium for fermentation culture at 40 deg.C until viable count reaches 4.2 × 109When cfu/ml is reached, ending the fermentation culture to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, wherein the temperature of a fermentation culture sample is 30 ℃, and when the number of viable bacteria reaches 4.5 × 109When cfu/ml is required, adding microcrystalline cellulose in the weight part of the example 8 into a fermentation medium, and fermenting for 50min to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, mixing for 40min, and then adding the glycyrrhizic acid, the pullulan, the maltose, the vitamin A, the vitamin C, the vitamin D and the vitamin B in the weight parts of the embodiment 86Mixing to obtain compound;
s4, sequentially granulating, rounding, drying at low temperature in vacuum and coating the compound obtained in the step S3 by using a granulator, a rounding machine, a dryer and a coating machine to obtain the probiotic preparation;
the main components of the fermentation medium comprise 88g/L of glucose, 12g/L of yeast extract, 11g/L of sodium citrate, 2.3g/L, L g/L of dipotassium phosphate-0.5 g/L of cysteine hydrochloride and 3.5g/L of magnesium sulfate.
Example 14A probiotic preparation and method of preparation
A preparation method of a probiotic preparation comprises the following steps:
s1, respectively inoculating the lactobacillus bulgaricus, the bifidobacterium lactis, the micrococcus krusei, the bacillus subtilis, the lactobacillus pentosus, the lactobacillus salivarius, the bacillus cereus and the yeast in the weight parts of the example 9 into a fermentation culture medium for fermentation culture, wherein the culture temperature is 40 ℃, and the viable count reaches 4.5 × 109When cfu/ml is reached, ending the fermentation culture to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, wherein the temperature of a fermentation culture sample is 35 ℃, and when the number of viable bacteria isUp to 3.8 × 109When cfu/ml is required, adding microcrystalline cellulose in the weight part of the example 9 into a fermentation medium, and fermenting for 1h to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, mixing for 40min, and then adding the glycyrrhizic acid, the pullulan, the maltose, the vitamin A, the vitamin C, the vitamin D and the vitamin B in the weight parts of the example 96Mixing to obtain compound;
s4, sequentially granulating, rounding, drying at low temperature in vacuum and coating the compound obtained in the step S3 by using a granulator, a rounding machine, a dryer and a coating machine to obtain the probiotic preparation;
the main components of the fermentation medium comprise 90g/L glucose, 14g/L yeast extract, 12g/L sodium citrate, 2.6g/L, L-dipotassium phosphate and 0.6g/L cysteine hydrochloride and 4g/L magnesium sulfate.
Example 15A probiotic formulation and method of preparation
A preparation method of a probiotic preparation comprises the following steps:
s1, respectively inoculating the lactobacillus bulgaricus, the bifidobacterium lactis, the micrococcus krusei, the bacillus subtilis, the lactobacillus pentosus, the lactobacillus salivarius, the bacillus cereus and the yeast in the weight parts of the example 10 into a fermentation culture medium for fermentation culture, wherein the culture temperature is 40 ℃, and the viable count reaches 4.3 × 109When cfu/ml is reached, ending the fermentation culture to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, wherein the temperature of a fermentation culture sample is 35 ℃, and when the number of viable bacteria reaches 3.5 × 109When cfu/ml is required, adding microcrystalline cellulose in the weight part of example 10 into a fermentation medium, and fermenting for 1h to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, mixing for 40min, and then adding the glycyrrhizic acid, the pullulan, the maltose, the vitamin A, the vitamin C, the vitamin D and the vitamin B in the weight parts of the embodiment 106Mixing to obtain compound;
s4, sequentially granulating, rounding, drying at low temperature in vacuum and coating the compound obtained in the step S3 by using a granulator, a rounding machine, a dryer and a coating machine to obtain the probiotic preparation;
the main components of the fermentation medium comprise 85-90 g/L of glucose, 5-14 g/L of yeast extract, 10-12 g/L of sodium citrate, 1-2.6 g/L, L-dipotassium phosphate, 0.2-0.6 g/L of cysteine hydrochloride and 2-4 g/L of magnesium sulfate.
Comparative example 1A probiotic preparation
Similar to example 15, except that: the probiotic preparation was free of glycyrrhizic acid and pullulan, and the remaining parameters were the same as in example 5.
Comparative example 2 a probiotic preparation
Similar to example 15, except that: the protective agent is added with glycyrrhizic acid only, and the other parameters are the same as the embodiment 15.
Comparative example 3A probiotic preparation
Similar to example 15, except that: the protective agent only contains pullulan, and the rest parameters are the same as those in example 15.
Comparative example 4 a probiotic preparation
Similar to example 15, except that: the mass ratio of glycyrrhizic acid to pullulan is 1: 1, the remaining parameters are the same as in example 15.
Comparative example 5A probiotic preparation
Similar to example 15, except that: the probiotic formulation was without addition of microcrystalline cellulose and the remaining parameters were the same as in example 15.
Comparative example 6A probiotic preparation
Similar to example 15, except that: microcrystalline cellulose was added after the fermentation of S.thermophilus and L.acidophilus was completed, and the remaining parameters were the same as in example 15.
Test example I determination of viable cell count
The probiotic preparations prepared in examples 11 to 15 and comparative examples 1 to 5 were stored in an environment with a temperature of 37 ± 2 ℃ and a humidity of 75 ± 5%, and the number of viable bacteria in the preparations was counted on days 0, 30 and 60, and the survival rate of the probiotic bacteria was calculated as the number of viable bacteria at the end of day 30 or at the end of day 60/the number of viable bacteria at day 0 × 100%, and the results are shown in table 1.
TABLE 1
Group of | Viable count/(cfu/g) at day 0 | 1 month survival/%) | Survival at month 2/%) |
Example 11 | 8.9×109 | 87 | 82 |
Example 12 | 9.5×109 | 85 | 81 |
Example 13 | 9.2×109 | 91 | 84 |
Example 14 | 9.4×109 | 93 | 87 |
Example 15 | 10.1×109 | 98 | 95 |
Comparative example 1 | 4.4×109 | 56 | 42 |
Comparative example 2 | 5.9×109 | 63 | 53 |
Comparative example 3 | 6.3×109 | 71 | 64 |
Comparative example 4 | 8.4×109 | 82 | 73 |
Comparative example 5 | 8.8×109 | 86 | 80 |
According to the data in table 1, the probiotic preparations prepared in examples 11 to 15 have a high viable bacteria count, and after 30 days and 60 days, the viable bacteria survival rate in the probiotic is still high, so that intestinal digestion and absorption can be promoted, and the balance of the intestinal flora ecosystem can be effectively adjusted, the probiotic preparation prepared in comparative example 1 (without adding a protective agent) has a lower viable bacteria count than the probiotic preparations prepared in examples 11 to 15, and the viable bacteria survival rate is lower, the protective agent in the probiotic preparation prepared in comparative example 2 or comparative example 3 only contains one of glycyrrhizic acid or pullulan, the viable bacteria count is lower, the survival rate is lower, the combination of glycyrrhizic acid and pullulan can improve the activity of the probiotic, compared with the probiotic preparation prepared in example 15, the viable bacteria count in comparative example 4 and the survival rate of bacteria are lower than those in example 15, the glycyrrhizic acid and the pullulan are required to be compounded according to a specific proportion so as to better improve the number of viable bacteria and the survival rate of bacteria; the probiotic preparation prepared in comparative example 5 (without microcrystalline cellulose addition) had little effect on the number of viable bacteria and the survival rate of the bacteria.
Test example two, effect of probiotic formulation on intestinal flora
The materials comprise 120 Kunming mice, half male and female, 22-24 g weight for feeding for 7 days, the Kunming mice are randomly divided into 12 groups, each group comprises 10 mice, the probiotic preparation prepared in examples 11-15 and comparative examples 1-5 is used, physiological saline is blank group, and positive group (10% intestines and stomach solution purchased from Beijing Bailin Kangyuan biotechnology Limited liability company, lactobacillus acidophilus is more than or equal to 7.5 × 107Enterococcus faecalis greater than or equal to 2.5 × 107) Feeding 0.2 mL/mouse in each group, wherein the test period is 4 weeks, collecting blood from eyeball of mouse at 4 weeks, aseptically picking thymus and spleen, collecting caecum content, and placing in 10% neutral formaldehyde buffer solution;
10% neutral formaldehyde buffer solution: accurately weighing 0.4gKH2PO4、0.65gK2HPO4Dissolved in a small amount of distilled water, stirred to mix well, and then 10mL of 40% formaldehyde solution was added thereto to adjust pH to 10 mL.
Mixing the collected cecum content and normal saline uniformly at a ratio of 1:9, placing on an oscillator, shaking for 20min, diluting by 10 times, uniformly coating on eosin methylene blue culture medium and MRS culture medium, respectively measuring the number of Escherichia coli and lactobacillus in cecum, placing in an aerobic incubator and an anaerobic incubator at 37 ℃ for 24h and 36h, respectively, and calculating the number of two types of bacteria in each gram of cecum content according to counting results.
TABLE 2
According to the data in table 2, after week 2, the difference between the colony numbers of the lactic acid bacteria in examples 11 to 15 and the colony numbers of the lactic acid bacteria in the blank group is not significant, but the colony numbers of the lactic acid bacteria in the examples 11 to 15 are significantly lower than that in the blank group, and with the increase of the feeding days, after week 4, the colony numbers of the lactic acid bacteria and the colony numbers of the lactic acid bacteria in examples 11 to 15 are significantly higher and lower than that in the blank group, respectively, and the colony numbers of the lactic acid bacteria in examples 11 to 15 are significantly increased (P < 0.01), and the colony numbers of the lactic acid bacteria are significantly reduced, which indicates that the probiotic preparation of the invention can promote the proliferation of the lactic acid bacteria, inhibit the propagation of the lactic acid bacteria, effectively regulate the balance of the.
Compared with the embodiment 15, the comparative example 1 has the advantages that the protective agent is not added, the number of the lactobacillus colonies is changed, the lactobacillus is easily affected and inactivated by bile salt in the intestinal tract, the number of the lactobacillus colonies is reduced, the number of the escherichia coli colonies is higher, the addition of the protective agent can enhance the number of the lactobacillus colonies, the number of the escherichia coli colonies is reduced, and the digestion and absorption are facilitated.
Compared with the example 15, the comparative example 2 or the comparative example 3 is only added with one of glycyrrhizic acid and pullulan, the increase of the colony number of the lactic acid bacteria is not large, the inhibition effect on the colony number of the escherichia coli is not strong, and the combination of the glycyrrhizic acid and the pullulan can improve the colony number of the lactic acid bacteria and inhibit the colony number of the escherichia coli.
Compared with the probiotic preparation prepared in the example 15, the probiotic preparation prepared in the example 4 has the effects of promoting the increase of the colony number of the lactic acid bacteria and inhibiting the colony of escherichia coli by changing the ratio of the glycyrrhizic acid to the pullulan.
Compared with the example 15, the probiotic preparation does not contain microcrystalline cellulose, and the effects on promoting the increase of the colony number of the lactic acid bacteria and inhibiting the colony number of escherichia coli are similar to and less than the effects of the example 15.
Test example three, accelerated test
The probiotic preparations prepared in examples 11 to 15 and comparative examples 1 to 6 were stored for 6 months at a temperature of 40 ℃. + -. 2 ℃ and a relative humidity of 75%. + -. 5%. Samples were taken at the end of 1 month, 2 months, 3 months, 6 months during the test period and the shape of the probiotic preparation was observed.
The results show that the probiotic preparations of examples 11 to 15 and comparative examples 1 to 4 of the present invention can be stored for a longer period of time without significant changes in the shape of the preparations, which indicates that the addition of microcrystalline cellulose before the fermentation of streptococcus thermophilus and lactobacillus acidophilus can increase the storage time of the probiotic preparations at room temperature, and thus the shape of the probiotic preparations is more stable. In contrast, in comparative example 5, no microcrystalline cellulose was added, and the formulation shape of the probiotic bacteria was dissolved, and in comparative example 6, the microcrystalline cellulose was dissolved after the fermentation of streptococcus thermophilus and lactobacillus acidophilus, and therefore, it was demonstrated that the shape of the formulation could be maintained and the shelf life of the probiotic formulation could be extended only by adding microcrystalline cellulose before the fermentation of streptococcus thermophilus and lactobacillus acidophilus was completed.
The foregoing embodiments are merely illustrative of the principles and utilities of the present invention and are not intended to limit the invention. Any person skilled in the art can modify or change the above-mentioned embodiments without departing from the spirit and scope of the present invention. Accordingly, it is intended that all equivalent modifications or changes which can be made by those skilled in the art without departing from the spirit and technical spirit of the present invention be covered by the claims of the present invention.
Claims (10)
1. The probiotic composition is characterized by comprising the following raw materials in parts by weight: 0.5-4 parts of streptococcus thermophilus, 0.5-2 parts of lactobacillus acidophilus, 0.5-2.5 parts of lactobacillus bulgaricus, 0.5-2 parts of bifidobacterium lactis, 0.5-1.5 parts of micrococcus krusei, 1.5-2.5 parts of bacillus subtilis, 0.5-1.5 parts of lactobacillus pentosus, 0.5-1.2 parts of lactobacillus salivarius, 2-4 parts of bacillus cereus, 0.5-1 part of saccharomycete and 6-10 parts of protective agent.
2. The probiotic composition according to claim 1, characterized by comprising the following raw materials in parts by weight: 0.5-2 parts of streptococcus thermophilus, 1-2 parts of lactobacillus acidophilus, 1-2.5 parts of lactobacillus bulgaricus, 1-2 parts of bifidobacterium lactis, 0.5-1 part of micrococcus krusei, 2-2.5 parts of bacillus subtilis, 0.5-1.5 parts of lactobacillus pentosus, 0.5-1.0 part of lactobacillus salivarius, 2-3 parts of bacillus cereus, 0.5-1 part of saccharomycete and 6-9 parts of a protective agent.
3. The probiotic composition according to claim 1, characterized by comprising the following raw materials in parts by weight: 1.8 parts of streptococcus thermophilus, 1.5 parts of lactobacillus acidophilus, 2 parts of lactobacillus bulgaricus, 1.6 parts of bifidobacterium lactis, 0.9 part of micrococcus klebsiella, 2.2 parts of bacillus subtilis, 1.0 part of lactobacillus pentosus, 0.8 part of lactobacillus salivarius, 2.5 parts of bacillus cereus, 0.6 part of yeast and 7 parts of protective agent.
4. The probiotic composition according to claim 1, characterized in that it further comprises maltose, vitamin a, vitamin C, vitamin D, vitamin B6And microcrystalline cellulose.
5. The probiotic composition according to claim 1, characterized in that the protective agent comprises glycyrrhizic acid and pullulan.
6. The probiotic composition according to claim 5, wherein the mass ratio of glycyrrhizic acid to pullulan is 1: (2.5-4).
7. A probiotic preparation prepared from the probiotic composition of any one of claims 1 to 6 and a pharmaceutically acceptable carrier.
8. The method for preparing a probiotic preparation according to claim 7, characterized in that it comprises the following steps:
s1, respectively inoculating lactobacillus bulgaricus, bifidobacterium lactis, micrococcus krusei, bacillus subtilis, lactobacillus pentosus, lactobacillus salivarius, bacillus cereus and saccharomycetes into a fermentation culture medium for fermentation culture, and ending the fermentation culture when the number of viable bacteria reaches a standard to obtain a fermentation culture solution I;
s2, inoculating streptococcus thermophilus and lactobacillus acidophilus into a fermentation culture medium for fermentation culture, and adding microcrystalline cellulose into the fermentation culture medium before fermentation is finished to obtain a fermentation culture solution II;
s3, mixing the fermentation culture solution I obtained in the step S1 with the fermentation culture solution II obtained in the step S2, and then adding glycyrrhizic acid, pullulan, maltose, vitamin A, vitamin C, vitamin D and vitamin B6Mixing to obtain compound;
and S4, sequentially granulating, rounding and vacuum drying the compound obtained in the step S3 to obtain the probiotic preparation.
9. The method for preparing probiotic preparation according to claim 8, wherein the number of viable bacteria in step S1 is 3.5-4.5 × 109And (5) finishing the fermentation culture when cfu/ml is reached.
10. The preparation method of the probiotic preparation according to claim 8, wherein the main components of the fermentation medium comprise 85-90 g/L of glucose, 5-14 g/L of yeast extract, 10-12 g/L of sodium citrate, 1-2.6 g/L, L g/L of dipotassium hydrogen phosphate and 0.2-0.6 g/L of cysteine hydrochloride, and 2-4 g/L of magnesium sulfate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010456985.4A CN111671090A (en) | 2020-05-26 | 2020-05-26 | Probiotic composition and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010456985.4A CN111671090A (en) | 2020-05-26 | 2020-05-26 | Probiotic composition and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111671090A true CN111671090A (en) | 2020-09-18 |
Family
ID=72434865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010456985.4A Pending CN111671090A (en) | 2020-05-26 | 2020-05-26 | Probiotic composition and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111671090A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115299610A (en) * | 2022-05-30 | 2022-11-08 | 吉林农业大学 | Intestinal probiotic composition and application thereof |
CN116135047A (en) * | 2023-03-14 | 2023-05-19 | 河北新希望天香乳业有限公司 | Pure cereal probiotic composition and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
CN101541194A (en) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | Probiotic oral dosage forms |
CN102198115A (en) * | 2011-05-19 | 2011-09-28 | 甘肃易源生物制药有限公司 | Enteric-coated micro-capsule prepared by mixing traditional Chinese medicine extract and probitics |
CN103764154A (en) * | 2011-06-10 | 2014-04-30 | 普洛特拉有限公司 | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
CN107287136A (en) * | 2017-07-06 | 2017-10-24 | 齐鲁工业大学 | A kind of preparation method of the prebiotic solid lactic acid bacteria agent with prebiotic function |
CN108783462A (en) * | 2018-07-02 | 2018-11-13 | 哈尔滨美华生物技术股份有限公司 | A kind of industrial process of beneficial bacteria of intestinal tract preparation |
-
2020
- 2020-05-26 CN CN202010456985.4A patent/CN111671090A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
CN101541194A (en) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | Probiotic oral dosage forms |
CN102198115A (en) * | 2011-05-19 | 2011-09-28 | 甘肃易源生物制药有限公司 | Enteric-coated micro-capsule prepared by mixing traditional Chinese medicine extract and probitics |
CN103764154A (en) * | 2011-06-10 | 2014-04-30 | 普洛特拉有限公司 | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
CN107287136A (en) * | 2017-07-06 | 2017-10-24 | 齐鲁工业大学 | A kind of preparation method of the prebiotic solid lactic acid bacteria agent with prebiotic function |
CN108783462A (en) * | 2018-07-02 | 2018-11-13 | 哈尔滨美华生物技术股份有限公司 | A kind of industrial process of beneficial bacteria of intestinal tract preparation |
Non-Patent Citations (8)
Title |
---|
NAPOLITANI: "Kocuria kristinae: an emerging pathogen in medical practice", 《JOURNAL OF MEDICAL MICROBIOLOGY》 * |
张晓芳: "甘草酸协同嗜酸乳杆菌对小鼠肠道微生态的影响", 《昆明理工大学硕士学位论文》 * |
张瑞琳: "《人体寄生虫学实验技术指南及彩色图谱》", 30 June 2013, 中山大学出版社 * |
李俊霞: "《现代常见病临床护理学(上)》", 1 March 2019, 吉林科学技术出版社 * |
杨红霞: "《药理学》", 31 July 2018, 同济大学出版社 * |
杨锐: "86株库克菌的鉴定与抗菌药物敏感性试验", 《国际检验医学杂志》 * |
江洪涛: "克氏库克菌感染的分析", 《上海畜牧兽医通讯》 * |
董佩佩: "乳酸菌贮存过程中耐湿保护剂的筛选", 《中国饲料》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115299610A (en) * | 2022-05-30 | 2022-11-08 | 吉林农业大学 | Intestinal probiotic composition and application thereof |
CN115299610B (en) * | 2022-05-30 | 2024-02-09 | 吉林农业大学 | Intestinal probiotics composition and application thereof |
CN116135047A (en) * | 2023-03-14 | 2023-05-19 | 河北新希望天香乳业有限公司 | Pure cereal probiotic composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108783462B (en) | Industrial production method of intestinal probiotic preparation | |
CN111534446B (en) | Lactobacillus reuteri and application thereof | |
CN100360658C (en) | Enteral microecological formulation and its preparation process | |
CN101366734A (en) | Synbiotics medicament composition | |
CN102206599B (en) | Oxygen-resistant acid-resistant Bifidobacterium longum | |
CN109679882B (en) | Enterococcus faecium DT1-1 and application thereof | |
CN114763520B (en) | Probiotic composition containing lactobacillus plantarum L137 and application thereof | |
CN111671090A (en) | Probiotic composition and preparation thereof | |
CN107164295A (en) | A kind of selenium-enriched microbe its preparation method and application | |
CN103283948A (en) | Bifidobacterium bifidum-oriented microecological preparation | |
CN113122466A (en) | Enterococcus faecalis and application thereof | |
CN103099821B (en) | High-dose bacillus licheniformis viable bacterium composition as well as preparation method and application thereof | |
CN115232768A (en) | Lactobacillus paracasei JN-8 and application thereof | |
CN112280707A (en) | Preparation method of probiotics for feed | |
CN102524794A (en) | Preparation method of serum cholesterol reduction Kluyveromyces marxianus freeze-dried powder | |
CN111616259A (en) | Production method of fermented dry feed capable of fully playing material adsorption role | |
CN105475988A (en) | Hybrid intestinal micro-ecologic preparation and preparation method thereof | |
CN117946913A (en) | Enterococcus faecalis XY3 and application thereof in preparation of hypoglycemic and anti-aging foods and medicines | |
CN118028148A (en) | Enterococcus faecalis MB2 and application thereof in preparation of anti-inflammatory and hypoglycemic foods and medicines | |
CN116970530B (en) | Bifidobacterium breve FPHC4024 for preventing and treating infantile diarrhea and application thereof | |
CN103283974A (en) | A method for producing a probiotic agent of live Lactobacillus bulgaricus | |
CN109593690B (en) | A kind of industrial process of beneficial bacteria of intestinal tract preparation | |
CN114984065B (en) | Probiotic composition for improving immunity and preparation method thereof | |
CN113397170B (en) | Application of marine prebiotics composition for regulating human intestinal flora | |
CN115011513A (en) | Lactic acid bacteria powder for enhancing immunity, regulating intestines and stomach to control fat, losing weight and expelling toxin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200918 |
|
RJ01 | Rejection of invention patent application after publication |